CLASS II Device recall · Reported 5 Mar 2014 · FDA Enforcement Report

PFC Sigma Cruciate Retaining (CR) recalled by DePuy Orthopaedics

DePuy Orthopaedics is recalling PFC Sigma Cruciate Retaining (CR), distributed in California, Florida, Iowa, Kentucky. The recall was initiated on 9 Dec 2013 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesCatalog Number 960015 Lot Numbers 7810268 and 7806929 (US) Lot Number 7806934 (OUS)
Quantity recalled2

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1077-2014
FDA event ID
67159
Recalling firm
DePuy Orthopaedics, Warsaw, IN
Classification
Class II
Status
Terminated
Recall initiated
9 Dec 2013
FDA classified
24 Feb 2014
Reported
5 Mar 2014
Type
Voluntary: Firm initiated
Customers notified by
Telephone
Reason category
Other Reasons

Timeline

9 Dec 2013Recall initiated by company
24 Feb 2014Classified by FDA+77 days
5 Mar 2014Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Knee implant femoral devices were found to have anomalous microstructure. Porosity and the presence of blocky carbides, within the cobalt chrome part, can decrease the overall fatigue strength. This decrease in strength could cause implants to fracture under what would normally be acceptable loads.

Product as listed by the FDA

PFC SIGMA Cruciate Retaining (CR); Cemented Femoral devices; (Size 5/RT) Used during primary total knee arthroplasty to improve patient mobility.

Where it was distributed

Worldwide Distribution-USA including the states of IA, CA, KY, and FL, and the countries of Finland, Germany, Sweden, and Czech Republic.

CaliforniaFloridaIowaKentucky

Questions about this recall

Why was it recalled?

Knee implant femoral devices were found to have anomalous microstructure. Porosity and the presence of blocky carbides, within the cobalt chrome part, can decrease the overall fatigue strength. This decrease in strength could cause implants to fracture under what would normally be acceptable loads.

Which lots are affected?

Catalog Number 960015 Lot Numbers 7810268 and 7806929 (US) Lot Number 7806934 (OUS)

Where was it sold?

Worldwide Distribution-USA including the states of IA, CA, KY, and FL, and the countries of Finland, Germany, Sweden, and Czech Republic.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from DePuy Orthopaedics

All 153

Other Hip & Knee Implants recalls

All 3,097